bioCSL has commenced distribution of Immucor’s Capture technology platform and reagents in Australia and New Zealand. Capture is antibody detection technology used in the crossmatching of blood used for transfusion.
The technology is said to work differently from the techniques commonly used in Australia, delivering high levels of specificity and potentially reducing both the need for additional testing and delays for patients awaiting a blood transfusion. The product has a high degree of sensitivity for detection of clinically significant antibodies, providing confidence and accuracy in pre‐transfusion and prenatal screening.
Phone: 1300 369 559
Amsbio StemFit Basic05 medium for scalable hPSC manufacturing
Compatible with both 2D adherent and 3D suspension culture, StemFit Basic05 enables a streamlined...
GeneTex carrier-free antibodies
GeneTex's carrier-fee antibodies are BSA-, sodium azide- and glycerol-free, featuring diverse...
Cayman Chemical LipidLaunch Ionizable Lipid LNP Screening Set
The LipidLaunch Ionizable Lipid LNP Screening Set is a screening set of 12 ionisable cationic and...
